| 1561 |
VERPAT |
PETHIDINE HYDROCHLORIDE BP 100 MG/2ML |
SOLUTION FOR INJECTION |
AMPOULES |
RELIEF OF MODERATE TO SEVERE PAIN, PRE-OPERATIVE MEDICATION AND ANALGESIA DURING ANAESTHESIA, AS AN ANALGESIC DURING LABOUR |
NULL |
LAO INTER PHARMA CO.,LTD |
VERVE HUMAN CARE LABOLATORIES |
INDIA |
CERTIFICATE RELEASED |
12 I 4862/19 |
26-AUG-2024 |
25-AUG-2027 |
View |
| 1562 |
VERZEPAM |
DIAZEPAM BP 10 MG/2ML |
SOLUTION FOR INJECTION |
AMPOULES |
TO RELIEVE ANXIETY AND PROVIDE SEDATION IN SEVERE ACUTE ANXIETY OR AGITATION AND FOR THE MANAGEMENT OF AGITATION ASSOCIATED WITH DELIRIUM TREMENS, ACUTE MUSCLE SPASM AND TETANUS. |
NULL |
LAO INTER PHARMA CO.,LTD |
VERVE HUMAN CARE LABOLATORIES |
INDIA |
CERTIFICATE RELEASED |
10 I 4601/18 |
26-AUG-2024 |
25-AUG-2027 |
View |
| 1563 |
ZETRO |
AZITHROMYCIN ( AS DIHYDRATE) 200 MG/5 ML |
ORAL SUSPENSION |
BOTTLE |
ZETRO (AZITHROMYCIN ) IS INDICATED FOR THE TREATMENT OF PATIENTS WITH MILD TO MODERATE INFECTIONS CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICRO-ORGANISMS IN THE SPECIFIC LISTED: LOWER AND UPPER RESPIRATORY INFECTION, UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, SEXUALLY TRANSMITTED DISEASE. |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
11 I 4111/15 |
10-Feb-2023 |
09-Feb-2026 |
View |
| 1564 |
ZETRO CAPSULE 250 MG |
AZITHROMYCIN (AS DIHYDRATE) 250 MG |
CAPSULE |
ALU-ALU |
ZETRO (AZITHROMYCIN ) IS INDICATED FOR THE TREATMENT OF PATIENTS WITH MILD TO MODERATE INFECTIONS CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICRO-ORGANISMS IN THE SPECIFIC LISTED: LOWER AND UPPER RESPIRATORY INFECTION, UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTIONS, SEXUALLY TRANSMITTED DISEASE. |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
11 I 4112/15 |
10-Feb-2023 |
09-Feb-2026 |
View |
| 1565 |
ZETRO TABLETS 500 MG |
AZITHROMYCIN (AS DIHYDRATE) 500 MG |
TABLET |
ALU-ALU BLISTER |
LOWER RESPIRATORY TRACT INFECTIONS, UPPER RESPIRATORY TRACT INFECTIONS, UNCOMPLICATED SKIN AND SKIN STRUCTURE INFECTION, SEXUALLY TRANSMITTED DISEASES |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
11 I 3930/13 |
18-AUG-2023 |
17-AUG-2026 |
View |
| 1566 |
ATORZET 10/10 |
ATORVASTATIN CALCIUM EQ.TO ATORVASTATIN 10 MG, EZETIMIBE 10 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
AS SUBSTITUTION THERAPY FOR TREATMENT OF ADULTS WITH PRIMARY (HETEROZYGOUS AND HOMOZYGOUS FAMILIAL AND NON-FAMILIAL) HYPERCHOLESTEROLAEMIA OR MIXED HYPERLIPIDAEMIA ALREADY CONTROLLED WITH ATORVASTATIN AND EZETIMIBE GIVEN CONCURRENTLY AT THE SAME DOSE LEVEL |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
MEDIWIN PHARMACEUTICALS |
INDIA |
CERTIFICATE RELEASED |
01 I 5680/24 |
06-FEB-2024 |
05-FEB-2027 |
View |
| 1567 |
DICLOXMAN-500 CAPSULE |
DICLOXACILLIN SODIUM EQ.TO DICLOXACILLIN 500 MG |
CAPSULE |
BOTTLE |
TREATMENT OF INFECTIONS CAUSED BY PENICILLINASE-RESISTANT STAPHYLOCOCCI |
NULL |
LAO INTER PHARMA CO.,LTD |
T MAN PHARMA COMPANY LIMITED |
THAILAND |
STEP 1: RECEIVE (RENEW) |
07 I 5241/22 |
17-Aug-2022 |
16-Aug-2025 |
View |
| 1568 |
ATORZET 10/20 |
ATORVASTATIN CALCIUM EQ.TO ATORVASTATIN 20 MG, EZETIMIBE 10 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
AS SUBSTITUTION THERAPY FOR TREATMENT OF ADULTS WITH PRIMARY (HETEROZYGOUS AND HOMOZYGOUS FAMILIAL AND NON-FAMILIAL) HYPERCHOLESTEROLAEMIA OR MIXED HYPERLIPIDAEMIA ALREADY CONTROLLED WITH ATORVASTATIN AND EZETIMIBE GIVEN CONCURRENTLY AT THE SAME DOSE LEVEL |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
MEDIWIN PHARMACEUTICALS |
INDIA |
CERTIFICATE RELEASED |
08 I 5595/23 |
05-SEP-2023 |
04-SEP-2026 |
View |
| 1569 |
BEVAAS 100 |
BEVACIZUMAB (R-DNA ORIGIN) 100 MG/4 ML |
SOLUTION FOR INFUSION |
VIAL |
METASTATIC COLORECTAL CANCER, NON SQUAMOUS NON SMALL CELL LUNG CANCER, GLIOBLASTOMA, METASTATIC RENAL CELL CARCINOMA, METASTATIC BREAST CANCER |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
HETERO BIOPHARMA LIMITED |
INDIA |
CERTIFICATE RELEASED |
12 I 5363/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
| 1570 |
BEVAAS 400 |
BEVACIZUMAB (R-DNA ORIGIN) 400 MG/16 ML |
SOLUTION FOR INFUSION |
VIAL |
METASTATIC COLORECTAL CANCER, NON SQUAMOUS NON SMALL CELL LUNG CANCER, GLIOBLASTOMA, METASTATIC RENAL CELL CARCINOMA, METASTATIC BREAST CANCER |
NULL |
LAO NIYOM PHARMA SOLE CO.,LTD |
HETERO BIOPHARMA LIMITED |
INDIA |
CERTIFICATE RELEASED |
12 I 5364/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
